Events1st International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-1 of the event 1st International Electronic Conference on Medicinal Chemistry
Published date
02 Nov, 2015
Citation
Térence Honoré, Annie Mayence, Tien L. Huang, Pascal Marchand, Identification of a Hit in a Small Library of Potential Antiplasmodial Imidazo[4,5-b]pyridines, in Proceedings of 1st International Electronic Conference on Medicinal Chemistry, 2 November–27 November 2015, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-1-A034
Share
Email
Facebook
Twitter
LinkedIn

Identification of a Hit in a Small Library of Potential Antiplasmodial Imidazo[4,5-b]pyridines

Térence Honoré 1
image
image
1. Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, LA, USA
2. Haute Ecole Provinciale de Hainaut Condorcet, B-7330 Saint-Ghislain, Belgium
3. Université de Nantes, Cibles et médicaments des infections et du cancer, IICiMed, EA 1155, F-44000, Nantes, France
Abstract

Recently we have demonstrated that some bis(oxyphenylene)benzimidazoles constituted potential antiplasmodial candidates but they are characterized by a high lipophilic character. To circumvent that drawback, two series of structural analogs have been prepared. In the first series, oxygen atoms have been introduced in the linker separating both pharmacophores. In the second series, the heterocyclic skeletons have been replaced by imidazo[4,5-b]pyridine moieties. The antiplasmodial activity of the newly synthesized compounds has been evaluated against the chloroquine-sensitive strain NF-54.  Their cytotoxicity in the presence of L6 rat skeletal muscle cells has also been determined. Among the active derivatives, 2,2’-[propane-1,3-diylbis(oxy-1,4-phenylène)]bis-1H-imidazo[4,5-b]pyridine emerged as the most promising hit.

Keywords
amidine
benzimidazole
imidazo[4,5-b]pyridine
plasmodium
Poster
1st IECMC-terence.pdf
Synthesis, Anticancer Activity and Molecular Docking Studies of Newer Quinoline Analogues
N-substituted ebselen derivatives and corresponding diselenides as the potential antitumor agents in prostate cancer model